TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07860021: VYVGART (Hytrulo) in Patients With Stiff Person Syndrome (SPS)

Sponsor: Thomas Jefferson University · Phase: PHASE2/PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 26 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$6,440,136

Rescue Site Savings

+$4,252,920

Unlock Full NCT07860021 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07860021 Rescue Dossier →